Diagnosis and treatment of superficial vein thrombosis

Hamostaseologie

Volumn 33, Issue 3, 2013, Pages 232-240

  Bauersachs Dr , R M ^a  

^a KLINIKUM DARMSTADT   (Germany)

Author keywords

Diagnosis; Epidemiology; Review; Superficial vein thrombosis; Treatment

Indexed keywords

DALTEPARIN; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; NAPROXEN; PLACEBO; TENOXICAM;

AGE; ANTICOAGULANT THERAPY; ARTICLE; AUTOIMMUNE DISEASE; BLEEDING; CARDIOVASCULAR RISK; CELLULITIS; COMPRESSION STOCKING; CONTRACEPTION; DEEP VEIN THROMBOSIS; DERMATITIS; DIFFERENTIAL DIAGNOSIS; DRUG DOSE COMPARISON; DRUG MEGADOSE; ERYSIPELAS; ERYTHEMA CHRONICUM MIGRANS; FAMILY HISTORY; GENDER; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HOSPITALIZATION; HUMAN; IMMOBILIZATION; INCIDENCE; INJURY; LOW DRUG DOSE; LYME DISEASE; MEDICAL HISTORY; NEOPLASM; OBESITY; PAIN; PERIPHERAL VEIN; PREGNANCY; PREGNANT WOMAN; PUERPERIUM; RISK FACTOR; RISK REDUCTION; SUPERFICIAL VEIN THROMBOSIS; THROMBOPHILIA; TREATMENT DURATION; ULTRASOUND; VARICOSIS; VEIN THROMBOSIS;

EID: 84881503801     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.5482/HAMO-13-04-0027     Document Type: Article

References (42)

1. Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS). Recommandations de bonne pratique. Prévention et traitement de la maladie thromboembolique veineuse en médecine. Recommandations. http://ansm.sante.fr/var/ansm_site/storage/original/application/ae4209ebc36d7164d4b7c876ddeaabab.pdf. Accessed 18 April 2009.
2. Belcaro G, Nicolaides AN, Errichi BM et al. Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study. Angiology 1999; 50: 523-529.
3. Cesarone MR, Belcaro G, Agus G et al. Management of superficial vein thrombosis and thrombophlebitis: status and expert opinion document. Angiology 2007; 58 (Suppl 1): 7S-15S.
4. De Maeseneer MGR, on behalf of the Thrombosis Guidelines Group of the Belgium Society on Thrombosis and Haemostasis and the Belgian Working Group on Angiology. Superficial thrombophlebitis of the lower limb: practical recommendations for diagnosis and treatment. Acta Chir Belg 2005; 105: 145-147.
5. Decousus H, Epinat M, Guillot K et al. Superficial vein thrombosis: risk factors, diagnosis, and treatment. Curr Opin Pulm Med 2003; 9: 393-397.
6. Decousus H, Frappe P, Accassat S et al. Epidemiology, diagnosis, treatment and management of superficial-vein thrombosis of the legs. Best Pract Res Clin Haematol 2012; 25: 275-284.
7. Décousus H, Leizorovicz A, Bauersachs R, et al. Fondaparinux for the treatment of superfical-vein thrombosis in the legs N Engl J Med 2010; 363: 1222-1232.
8. Decousus H, Quere I, Presles E et al. Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study. Ann Intern Med 2010; 152: 218-224.
9. Decousus H, Bertoletti L, Frappé P et al. Recent findings in the epidemiology, diagnosis and treatment of superficial-vein thrombosis. Thromb Res 2011; 127 (Suppl 3): S81-S85.
10. Di Minno G, Mannucci PM, Tufano A et al. The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism. J Thromb Haemost 2005; 3: 1459-1466.
11. Di Nisio M, Wichers IM, Middeldorp S. Treatment for superficial thrombophlebitis of the leg. Cochrane Database Syst Rev 2007: CD004982.
12. Di Nisio M, Wichers IM, Middeldorp S. Treatment for superficial thrombophlebitis of the leg. Cochrane Database Syst Rev 2012; 3: CD004982.
13. Galanaud JP, Bosson JL, Genty C et al. Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies. J Thromb Haemost 2012; 10: 1004-1011.
14. Galanaud JP, Genty C, Sevestre MA et al. Predictive factors for concurrent deep-vein thrombosis and symptomatic venous thromboembolic recurrence in case of superficial venous thrombosis. The OPTIMEV study. Thromb Haemost 2011; 105: 31-39.
15. Goldman L, Ginsberg J. Superficial phlebitis and phase 3.5 trials. N Engl J Med 2010; 363: 1278-1280.
16. Hafner CD, Cranley JJ, Krause RJ, Strasser ES. A Method of Managing Superficial Thrombophlebitis. Surgery 1964; 55: 201-206.
17. Husni EA, Williams WA. Superficial thrombophlebitis of lower limbs. Surgery 1982; 91: 70-74.
18. Jeanneret C, Brunner S. Superficial venous thrombosis. A review. Hautarzt 2012; 63: 609-615.
19. Jeanneret C, Baldi T, Jenelten R. La thrombophlébite superficielle: une vue d'ensemble. Recommandé/accrédité par la Société Suisse de Médecine Générale et la Société Suisse de Médecine Interne. Forum Médical Suisse 2006; 6: 190-195.
20. Kearon C, Kahn SR, Agnelli G et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th ed). Chest 2008; 133(6 Suppl): 454S-545S.
21. Kearon C. Extended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated. J Thromb Thrombolysis 2011; 31: 295-300.
22. Leizorovicz A, Prandoni P, Decousus H, on behalf of the Steering Committee of the CALISTO Study. Fondaparinux reduces all types of symptomatic thromboembolic complications in patients with superficial-vein thrombosis in the legs: data from the CALISTO study. Blood 2011; 118: 2310.
23. Leon L, Giannoukas AD, Dodd D, Chan P, Labropoulos N. Clinical significance of superficial vein thrombosis. Eur J Vasc Endovasc Surg 2005; 29: 10-17.
24. Lozano FS, Almazan A. Low-molecular-weight heparin versus saphenofemoral disconnection for the treatment of above-knee greater saphenous thrombophlebitis: a prospective study. Vasc Endovascular Surg 2003; 37: 415-420.
25. Lutter KS, Kerr TM, Roedersheimer LR et al. Superficial thrombophlebitis diagnosed by duplex scanning. Surgery 1991; 110: 42-46.
26. Marchiori A, Verlato F, Sabbion P et al. High versus low doses of unfractionated heparin for the treatment of superficial thrombophlebitis of the leg. A prospective, controlled, randomized study. Haematologica 2002; 87: 523-527.
27. Partsch H, Mostbeck A. Lungenembolien bei oberflächlicher Thrombophlebitis? Acta med Austr 1979; 6: 159.
28. Plate G, Eklof B, Jensen R, Ohlin P. Deep venous thrombosis, pulmonary embolism and acute surgery in thrombophlebitis of the long saphenous vein. Acta Chir Scand 1985; 151: 241-244.
29. Prandoni P, Casiglia E, Tikhonoff V et al. Calisto Investigators. The risk of subsequent cancer and arterial cardiovascular events in patients with superficial vein thrombosis in the legs. Blood 2011; 118: 4719-4722.
30. Quenet S, Laroche JP, Bertoletti L et al. Value of a planned compression ultrasonography after an isolated superficial vein thrombosis: results from a prospective multicentre study. Eur J Vasc Endo - vasc Surg 2012; 43: 233-237.
31. Quéré I, Decousus H, Leizorovicz A. Risk Factors For Concomitant Venous Thromboembolism (VTE) In Patients With Superficial Thrombophlebitis (ST): Preliminary Results Of The POST Study. J Thromb Haemost 2007; 5( Suppl 2): P-S-600.
32. Rabe E, Bauersachs R, Pannier F. Dalteparin in patients with superficial leg vein thrombophlebitis (SVT) in addition to compression treatment - a placebo-controlled phase III study. 50 Union Int Phlebologie, Monaco 2009.
33. Sorensen HT, Svaerke C, Farkas DK et al. Superficial and deep venous thrombosis, pulmonary embolism and subsequent risk of cancer. Eur J Cancer 2012; 48: 586-593.
34. Talbot SR. B-mode evaluation of peripheral veins. Semin Ultrasound CT MR 1988; 9: 295-319.
35. The Stenox Study Group. A pilot randomized double-blind comparison of a low-molecularweight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis. Arch Intern Med 2003; 163: 1657-1663.
36. The Vesalio Investigators Group. High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs: a double-blind, randomized trial. J Thromb Haemost 2005; 3: 1152-1157.
37. Titon JP, Auger D, Grange P et al. Therapeutic management of superficial venous thrombosis with calcium nadroparin. Dosage testing and comparison with a non-steroidal anti-inflammatory agent. Ann Cardiol Angeiol (Paris) 1994; 43: 160-166.
38. Van Langevelde K, Lijfering WM, Rosendaal FR, Cannegieter SC. Increased risk of venous thrombosis in persons with clinically diagnosed superficial vein thrombosis: results from the MEGA study. Blood 2011; 118: 4239-4241.
39. Verlato F, Zucchetta P, Prandoni P et al. An unexpectedly high rate of pulmonary embolism in patients with superficial thrombophlebitis of the thigh. J Vasc Surg 1999; 30: 1113-1115.
40. Wichers IM, Haighton M, Buller HR, Middeldorp S. A retrospective analysis of patients treated for superficial vein thrombosis. Neth J Med 2008; 66: 423-427.
41. Widmer L. Venenkrankheiten, Häufigkeit und sozialmedizinische Bedeutung. Bern: Hans Huber 1978.
42. nd Basel study. Zentralbl Phlebol 1967; 6: 257-264.